Manebio

Manebio is a biotechnology company focused on the emerging field of mechanobiology to develop novel therapeutics for diseases driven by mechanical force sensing. The company leverages a proprietary platform to identify and modulate mechanosensitive ion channels and proteins that play critical roles in physiological processes like blood pressure regulation and touch sensation. By targeting these mechanical pathways, Manebio aims to address unmet needs in cardiovascular, neurological, and genetic disorders. The company's approach represents a shift from traditional chemical signaling to physical signaling in drug discovery.